Multicenter Hospital-Based Prospective Surveillance Study of Bacterial Agents Causing Meningitis and Seroprevalence of Different Serogroups of Neisseria meningitidis, Haemophilus influenzae Type b, and Streptococcus pneumoniae during 2015 to 2018 in Turkey

Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis—Active Bacterial Core Surveillance Sites, 2011–2016

(2019) Lucy A McNamara et al.   Open Forum Infectious Diseases

Meningococcal B vaccine (4CMenB): the journey from research to real world experience

(2018) Rino Rappuoli et al.   Expert Review of Vaccines

Meningococcal serogroups and surveillance: a systematic review and survey

(2018) Meagan E Peterson et al.   Journal of Global Health

Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative

(2017) Ray Borrow et al.   JOURNAL OF INFECTION

The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey

(2017) Rahmi Tuna Tekin et al.   Human Vaccines & Immunotherapeutics

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

(2017) Lucy A. McNamara et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Bacterial agents causing meningitis during 2013–2014 in Turkey: A multi-center hospital-based prospective surveillance study

(2016) Mehmet Ceyhan et al.   Human Vaccines & Immunotherapeutics

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

(2015) Matthew R Moore et al.   LANCET INFECTIOUS DISEASES

First case ofNeisseria meningitidiscapsule null locus infection in China

(2015) Zheng Xu et al.   Infectious Diseases

Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America

(2014) R. ABAD et al.   EPIDEMIOLOGY AND INFECTION

Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae Type B and Streptococcus Pneumoniae during 2005–2012 in Turkey

(2014) Mehmet Ceyhan et al.   Human Vaccines & Immunotherapeutics

The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review

(2013) Stephanie Davis et al.   BMC PUBLIC HEALTH

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X

(2013) F. Micoli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

(2013) Anneke Steens et al.   VACCINE

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

(2013) Daniel R. Feikin et al.   PLOS MEDICINE

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

(2010) J. Donnelly et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines

(2009) Daniel J. Isaacman et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Meningococcal carriage and disease—Population biology and evolution

(2009) Dominique A. Caugant et al.   VACCINE

Serotype replacement in perspective

(2009) Ron Dagan   VACCINE

Influence of Admission Findings on Death and Neurological Outcome from Childhood Bacterial Meningitis

(2008) Irmeli Roine et al.   CLINICAL INFECTIOUS DISEASES